1013033-83-4

Basic information

• Product Name: 7-Boc-1-oxo-3-phenyl-2,7-diaza-spiro[3.5]nonane
• Synonyms: 7-Boc-1-oxo-3-phenyl-2,7-diaza-spiro[3.5]nonane
• CAS NO: 1013033-83-4
• Molecular Formula: C₁₈H₂₄N₂O₃
• Molecular Weight: 316.39476
• Mol File: 1013033-83-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-Boc-1-oxo-3-phenyl-2,7-diaza-spiro[3.5]nonane(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Boc-1-oxo-3-phenyl-2,7-diaza-spiro[3.5]nonane(1013033-83-4)
• EPA Substance Registry System: 7-Boc-1-oxo-3-phenyl-2,7-diaza-spiro[3.5]nonane(1013033-83-4)

Safety Data

• Hazardous Substances Data: 1013033-83-4(Hazardous Substances Data)

Upstream product

• 100-52-7 benzaldehyde 
• 142851-03-4 1-tert-butyl 4-ethyl piperidine-1,4-dicarboxylate 
• 17599-61-0 N-benzylidene-1,1,1-trimethylsilanamine 

Downstream Products

• 1013033-86-7 C₂₄H₂₈N₂O₃ 
• 1013034-50-8 1,1-dimethylethyl 1-phenyl-2,7-diazaspiro[3.5]nonane-7-carboxylate 
• 1446652-89-6 (2S,4S)-1-(2,2-diphenylacetyl)-4-(1-oxo-3-phenyl-2,7-diazaspiro[3.5]nonan-7-yl)pyrrolidine-2-carboxylic acid 
• 1446654-42-7 C₃₃H₃₅N₃O₄ 
• 1446654-41-6 C₁₃H₁₆N₂O*ClH 

Relevant articles and documents

Spiro-piperidine azetidinones as potent TRPV1 antagonists

A series of spiro-piperidine azetidinone were synthesized and evaluated as potential TRPV1 antagonists. An important issue of plasma stability was investigated and resolved. Further focused SAR study lead to the discovery of a potent antagonist with good

TREATING PAIN, DIABETES, AND DISORDERS OF LIPID METABOLISM

Disclosed is a method of treating a disease or condition (e.g., pain, diabetes or disorders of lipid metabolism) comprising administering an azetidine derivative of the formula I selected from the group consisting of the compounds defined by Tables 1, 2,